DEX yields 2.60% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, DEX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DEX + MRK for your $10,000?
Delaware Enhanced Global Dividend and Income Fund is a closed ended balanced mutual fund launched by Delaware Management Holdings, Inc. The fund is managed by Delaware Management Business Trust. It invests in public equity and fixed income markets across the globe. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in dividend paying stocks of large-cap companies. For its fixed income portion, the fund invests in debt securities such as government bonds, investment grade and high risk, high yield corporate bonds, and convertible bonds. It also invests in emerging market securities. The fund benchmarks the performance of its portfolio against the S&P 500 Index, the Lipper Closed-End Global Funds Average, the FTSE EPRA/NAREIT Developed Index, and the BoFA Merrill Lynch U.S. High Yield Constrained Index. Delaware Enhanced Global Dividend and Income Fund was formed on June 29, 2007 and is domiciled in the United States.
Full DEX Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.